Study of relationship between Homocystine and Atherosclerosis
DOI:
https://doi.org/10.51699/ijhsms.v2i10.2659Abstract
In this study the effect of amino acid metabolism via determination of homocystiene blood glucose to determination sugar in blood. The study conducted on too Iraqi patient with chronic atherosclerosis at age rang (29-70years) in Baquba teaching hospital in (center care unit) during the period from 25 September 2020to may 2021. The patients divided in (55 mans and 45 patients) the total patient divided in tow groups according the treatment (30) of total patient under go to treatment for two to three days after atherosclerosis and 70 patient in same day of diagnosis of atherosclerosis. Atherosclerosis effect on HCY value where the results observed decreasing compare with control.
Downloads
References
Lorkowski S, Cullen P. Atherosclerosis: pathogenesis, clinical features and treatment. Encycl Life Sci. 2007; 2007:1–11.
Cardiovascular disease [Internet]. Eciclopaedia Britannica. [cited 2014 Dic 18.
Khosravi A, Peyman P, Sayemiri K, Saki K, Ranjbar R. Evaluation of Sera Hemocystein and Lipoprotein (a) levels in relation to other risk factors of cardiovascular diseases. Health System Research. 2010; 6(2): 326-334.
Kazemi T, Sharif Zadeh GhR. Ten-year changes in mortality and risk factors in acute myocardial infarction in Birjand, 1994-2003. Ofogh-e-Danesh. 2004; 10(3): 38-42.
Ghatreh Samani K, Roghani F, Farrokhi E. Evaluation of correaltion between plasma homocysteine and oxidized low-density lipoprotein in patients with coronary artery disease. Journal of Birjand University of Medical Sciences. 2009; 16 (3): 47-53.
Frick B, Rudzite V, Schrocksnadel K, Kalnins U, Erglis A, Trusinskis K, et al. Homocysteine, B vitamins and immune activation in coronary heart disease. Pteridines-Berlin-. 2003; 14(3): 82-7.
Voutilainen S, Lakka T, Hämelahti P, Lehtimäki T, Poulsen H, Salonen J. Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Studytpdel. Journal of internal medicine. 2000; 248(3): 217-22.
Chauhan AP, Tailor PB, Joshi R, Bhabhor P. Evaluation of Serum Homocysteine as an Independent Risk Factor for Myocardial Infarction in Young Patients. National Journal of Medical Research. 2012; 2(4): 423-6.
Bełtowski J. Protein homocysteinylation: a new mechanism of atherogenesis? Modyfikacja białek przez tiolakton homocysteiny–nowy mechanizm powstawania miażdżycy? Journal cover. 2013; 67.
Voutilainen S, Virtanen JK, Rissanen TH, Alfthan G, Laukkanen J, Nyyssönen K, et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. The American journal of clinical nutrition. 2004; 80(2): 317-23.
Qujeq D, Hossini L, Salehi Omran MT. Relationship of Total Homocysteine, Cholesterol, Triglyceride in the Serum and Diastolic Blood Pressure of Patients with Myocardial Infarction. Iranian Biomedical Journal. 2001; 5(2): 97-101.
Paul Ganguly and Sreyoshi Fatima Alam " Role of homocysteine in the development of cardiovascular disease" Nutrition journal " 14: 6(2015).
